Skip to main content
Mædica logoLink to Mædica
. 2016 Sep;11(3):203–207.

Antimicrobial Resistant Pattern and Capsular Typing of Streptococcus Pneumoniae Isolated from Children in Sistan –Baluchestan

Zahra GHARAILOO 1, Seyed Fazlollah MOUSAVI 2, Niloofar HALVANI 3, Mohammad Mehdi FEIZABADI 4
PMCID: PMC5486161  PMID: 28694854

Abstract

Background:

Ankyloglossia is an anatomic developmental anomaly determining by thick and short, fi brotic ferenum. Tongue changes have severe eff ects on occlusion and oropharyngeal structures. The aim of this study was to evaluate the position of hyoid in children 7-11 years` old with ankyloglossia in lateral cephalometric radiographs.

Materials and method:

In this study 260 nasopharyngeal swabs were taken from non-vaccinated healthy children between 6 months to 6 years old at medical centers in Sistan-Baluchestan during August 2013 to January 2014. These samples were cultured on blood agar. Primary identifi cation of bacterial isolated was determined by biochemical analysis and molecular tests. Capsular typing was performed by Multiplex PCR using primers targeting cps locus that is highly conserved among diff erent capsular types. The master mixes for PCR were grouped them into six multiplex reactions.

Results:

Out of 260 nasopharyngeal swabs, 42 isolates of Streptococcus pneumoniae were detected and identifi ed. The overall pneumococcal carriage rate was 16.1%. The most frequently isolated capsular types were: 6A/B, 19A, 19F and 23F. These capsular types accounted for 49.9% of all strains detected.

Conclusion:

We found that the prevalence of pneumococcal carriage among non-vaccinated children under six years old is about 16%. Our study provides much data about carriage rate and pneumococcal capsular types in preschool children, which is necessary for predicting the diff erent valent pneumococcal conjugated vaccines in Iran.

BACKGROUND

Streptococcus pneumoniae (S. pneumoniae) is an important cause of morbidity and mortality among young children and the elderly people (1). Nearly one million children under age 5 die of pneumococcal diseases every year (2). In recent years treatment of infections with this organism is difficult because of acquiring resistance to the antibiotics (1, 3, 4). Capsule is an important virulence factor in S. pneumoniae isolates causing infectious diseases (sepsis, pneumonia, meningitis, otitis media, sinusitis and bronchitis) (1, 5). As yet, 94 capsular serotypes have been identified in S. pneumoniae but few of them (4, 6B, 9V, 14, 18C, 19F and 23F) have been associated with invasive pneumococcal diseases (IPD) (1). However, predominant serotypes may vary depending on geographic location at different times (4, 6). A suitable vaccine can prevent pneumococcal infections and reduce the mortality rate. Today, many conjugate vaccines are in use for the prevention of infection with this bacterium. A 7-valent and 13- valentant pneumococcal vaccines are already licensed in several countries (1, 7, 8). These vaccines contain trains cause most severe infections in children and about half of infections in adults. However, recent studies show infection with capsular serotypes other than serotypes used in vaccines is growing, PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) reduced IPD across all age groups when used routinely in children in the USA (9). Here is evidence that routine childhood vaccination reduces the burden of pneumococcal disease in adults and especially highrisk adults, such as those living with HIV/AIDS (9, 10). Hence serotyping is important in following up the vaccination outcome and tracing the emergence of non-vaccine strains. Multiplex PCR is a rapid, simple, and cost-effective molecular method to identify pneumococcal serotypes (10).

Although previous studies showed a high prevalence of pneumococcal disease and high antimicrobial resistance of S. pneumoniae strains in Iran, little information is available on the serotypes distribution of S. pneumoniae in different parts of country.

The aim of this study was to determine the most predominant pneumococcal serotypes among non-vaccinated children under 6 years old in Sistan-Baluchestan, using Multiplex PCR method.

MATHERIAL AND METHODS

1.1-Bacterial isolates:

A total of 260 nasopharyngeal swabs were collected from non-vaccinated healthy children between 6 months to 6 years old at medical centers in Sistan- Baluchestan, Iran from August 2013 to January 2014. Swab samples were transferred into STGG transfer medium (Skimmed milk, Tryptone, Glucose, and Glycerol) and subsequently inoculated into 5% sheep blood agar and incubated overnight at 37°C in 5% CO2. The isolated colonies were then identified to species level using standard biochemical methods (11). The identity of isolates as S. pneumoniae was confirmed by PCR using primers targeting cpsA gene as described previously (12). S. pneumoniae ATCC 6305 was used as a control in experiments.

1.2- Antimicrobial Susceptibility testing:

The CLSI protocol for disk diffusion test was used to assess the susceptibility of isolates to Tetracycline (30μg), Gentamicin (10μg), Cotrimoxazole (25μg), Oxacillin (1μg), Amoxicillin (25μg), Vancomycin (30μg), Erythromycin (15μg), Chloramphenicol (30μg), Cefotaxime (30μg) and Levofloxacin (5μg).

1.3- DNA extraction:

Genomic DNAs were extracted using a DNA extraction Kit (Metabion™ international AG, Germany) according to the manufacture’s protocol. Finally, the harvested DNA pellet was re-suspended in RNase- Tris-EDTA to provide 70 μl of DNA sample.

1.4. PCR conditions:

The primers were designed based on the sequences available for the capsular types 1, 3, 4, 5, 6A/B, 7F, 9V, 10A, 11, 12, 14, 15, 16, 18C, 19F, 19A, 22, 23F, 33F, and 35B. The primers were used in six different multiplex PCR according to the previously described method (13). Primers have been designed and grouped on major serotypes of invasive and non-invasive isolates exist in different geographical areas (shown in table 1). S. pneumoniae type strains including ATCC 6305, ATCC 6301, ATCC 49619; ATCC 49136 and ATCC 700677 were used as positive control.

Table 1.

Table 1.

Table 1. Classifi cation of serotypes to molecular capsular typing and the oligonucleotide primers used in this study.

Table 2.

Table 2.

Table 2. Classifi cation of serotypes to molecular capsular typing and the oligonucleotide primers used in this study.

RESULTS

Of 260 nasopharyngeal swabs from children under the age of five years, 74 (28.5%) isolates were identified as Streptococcus pneumoniae using standard biochemical tests while only 42 isolates (16.1%) were confirmed as S. pneumoniae by PCR.

The maximum resistance was observed against oxacillin (100%) followed by cotrimoxazole (93%), tetracycline (61%), erythromycin (56%), gentamicin (46%), amoxicillin (18%) and chloramphenicol (16%). All isolates were susceptible to cefotaxime, vancomycin and levofloxacin.

Multiplex reaction assembly:

The results of the capsular typing are shown in Table 2 and Figure 1. Isolates were assigned into six different capsular types. Of 42 isolates, 11 could not be typed by this method. The predominant capsular types (40%) were identified in reactions 1 and 4. These reactions showed 19% and 12% of capsular types were 6A/B and 19A respectively. No capsular types were identified in reaction 6.

DISCUSSION

S. pneumoniae is one of the most common causes of morbidity and mortality in children less than six years and causes life-threatening infections such as meningitis, pneumonia, and febrile bacteremia (14). Serotyping is conventionally based on the Quellung reaction with anticapsular sera, but this is expensive, labor-intensive, and prone to errors (13). PCR-based typing methods including capsular typing are easier, faster, and cost benefit to perform (1). Determination of capsular serotypes is also important for vaccine development since there is difference on the distribution of capsular serotypes causing infection at various areas (15).

According to this study, cefotaxime was the most effective antibiotics against isolates of S. pneumoniae followed by vancomycin and levofloxacin which 100% of the isolates were susceptible to all three mentioned antibiotics completely.

Figure 1.

Figure 1.

Figure 1. Multiplex PCR reactions. Reaction 1 (A); M: size marker, 19A: 478 bp, 6A/B: 250bp. Reaction 2 (B); 14: 280 bp. Reaction 3 (C); 23F: 384 bp. Reaction 4 (D); 19F: 304 bp and 16: 988 bp.

By using multiplex- PCR, 4 isolates couldn’t be typed. The remainders were successfully classified into 6 different capsular types. In this survey, similar to other studies from Asia (16, 17), the majority of isolates were typed by three first reactions set in which 6A/B, 19A , 19F and 23F were the predominant capsular types respectively. These results differ somewhat from the results of other studies performed in this field in Iran (11, 18, 19, 21). In previously reported study from Tehran, capsular types 19F and 19A were the most common types and according to the study which is performed by Sanai et al in 2012, the most predominant serotypes were 6, 14, 17, 19, 20, 21, and 23; although in this recent study, serotyping was investigated by quelling test which is less precise than the molecular methods (18, 19, 20). In a study conducted in 2011 in Zahedan, 1,19A,15C,9V,11A,19F were the most predominant capsular types that performed by latex agglutination test (22), while in the present study, the most frequent capsular type was 6 A/B though capsular types 19A and 19F had the next ranks. The differences may be due to the use of different methods for serotyping, different geographical area or may indicate a change in the dominant clone. Given that most of the capsular serotypes obtained in this study are invasive serotypes; their nasopharyngeal colonization in children can be a sign of a lack of proper use of vaccines for prevention in this area. Although all studies that has been done indicate that Serotypes prevalent in most parts of Iran, Similar to serotypes contained in the Pneumococcal Conjugate Vaccines (7 and 13 PCV). According to these results, a few pneumococcal serotypes have been related to the majority of nasopharyngeal carriage and invasive disease (23). It appears that the 7-valent and 13-valent vaccine are suitable for prevention of pneumococcal infections in Iran. However, based on this study PCV13 could cover more serotypes than the others. The vaccine can reduce the risk of life-threatening IPD diseases if properly used, especially in areas prone to infection by this bacterium. In a statistical experiment, among 37868 healthy children carrying S. pneumoniae in their nasopharynx who had received at least one dose of conjugate vaccines; invasive pneumococcal disease incidence has decreased to 89% (24). Given that the highest risk group for infection with this bacterium is children less than 6 years; the groups investigated in this study, lack of regular vaccination program increases the risk of fatal infection and impose high costs to the health system (25, 26). However to determine the actual position of serotypes and evaluating the effectiveness of the vaccine used serotyping should be done on more specimens.

Conflict of interests: none declared.

Financial support: none declared.

Contributor Information

Zahra GHARAILOO, Department of Microbiology, School of Medicine, Tehran University of Medical Science, Tehran, Iran..

Seyed Fazlollah MOUSAVI, Department of Bacteriology and Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran..

Niloofar HALVANI, Faculty of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Mohammad Mehdi FEIZABADI, Department of Microbiology, School of Medicine, Tehran University of Medical Science, Tehran, Iran.

REFERENCES

  1. Raymond F, Boucher N, Allary R, et al. Serotyping of Streptococcus pneumoniae Based on Capsular Genes Polymorphisms. PLoS ONE. 2013;8:e76197. doi: 10.1371/journal.pone.0076197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. No authors listed. - Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. WklyEpidemiol Rec. 2007;82:93–104. [PubMed] [Google Scholar]
  3. Brito DA, Ramirez M, Lencastre H. - Serotyping Streptococcus pneumoniae by Multiplex PCR. JCM. 2003:2378–2384. doi: 10.1128/JCM.41.6.2378-2384.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Linares J, Ardanuy C, Pallares R, et al. - Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. CMI. 2010;16:402–410. doi: 10.1111/j.1469-0691.2010.03182.x. [DOI] [PubMed] [Google Scholar]
  5. Henrichsen, J. - Six newly recognized types of Streptococcus pneumoniae. JCM. 1995;33:2759–2762. doi: 10.1128/jcm.33.10.2759-2762.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ochoa TJ, Rupa R, Guerra H, et al. - Penicillin resistance and serotypes/ serogroups of Streptococcus pneumoniae in nasopharyngeal carrier children younger than 2 years in Lima, Peru. Diagn Microbiol Infect Dis. 2005;52:59–64. doi: 10.1016/j.diagmicrobio.2004.12.014. [DOI] [PubMed] [Google Scholar]
  7. Coles CL, Sherchand JB, Khatry SK, et al. - Nasopharyngeal carriage of S. pneumoniaeamong young children in rural Nepal. TMIH. 2009:1025–1033. doi: 10.1111/j.1365-3156.2009.02331.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Siira L, Ka. alainen T, Lambertsen L, et al. - From Quellung to multiplex PCR, and back when needed, in pneumococcal serotyping. JCM. 2012;50:2727–273. doi: 10.1128/JCM.00689-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hicks LA, - Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. JID. 2007;196:1346–1354. doi: 10.1086/521626. [DOI] [PubMed] [Google Scholar]
  10. Zzari C, Moriondo M, Indolfi G, et al. - Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease. PLOS ONE. 2010;5:e9282. doi: 10.1371/journal.pone.0009282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mousavi SF, Nobari S, Ghezelgeh FR, et al. - Serotyping of Streptococcus pneumoniae isolated from Tehran by Multiplex PCR: Are serotypes of clinical and carrier isolates identical? IJM. 2013;5:220–226. [PMC free article] [PubMed] [Google Scholar]
  12. Mavroidi A, Godoy D, Aanensen DM, et al. - Evolutionary genetics of the capsular locus of serogroups 6 pneumococci. SGM. 2004;186:8181–8192. doi: 10.1128/JB.186.24.8181-8192.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Pai R, Gertz RE, Beall B. - Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. JCM. 2006;44:124–131. doi: 10.1128/JCM.44.1.124-131.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. O’Brien KL, Wolfson LJ, Wa$ JP, et al. - Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. LANCET. 2009;374:893–902. doi: 10.1016/S0140-6736(09)61204-6. [DOI] [PubMed] [Google Scholar]
  15. Feikin DR, Klugman KP. - Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines. PLOS ONE. 2002;35:547–555. doi: 10.1086/341896. [DOI] [PubMed] [Google Scholar]
  16. Saha SK, Baqui AH, Darmstadt GL, et al. – Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. JCM. 2003;41:5582–5587. doi: 10.1128/JCM.41.12.5582-5587.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Coles CL, Kanungo R, Rahmathullah L, et al. - Pneumococcal nasopharyngeal colonization in young South Indian infants. PIDJ. 2001;20:289–295. doi: 10.1097/00006454-200103000-00014. [DOI] [PubMed] [Google Scholar]
  18. Tabatabaei SR, Fallah F, Shiva F, et al. - Multiplex PCR Assay for Detection of Pneumococcal Serotypes in Nasopharyngeal Samples of Healthy Children; Tehran. SCIENCE DOMAIN. 2014 [Google Scholar]
  19. Hajia M, Rahbar M, Farzami MR, et al. - Effi cacy of multiplex PCR procedure for Iranian Streptococcus pneumoniae isolates. CJIM. 2014;5:109. [PMC free article] [PubMed] [Google Scholar]
  20. Sanaei Dashti A, Abdinia , Karimi A. - Nasopharyngeal carrier rate of Streptococcus pneumoniae in Children: Serotype distribution and antimicrobial resistance. AIM. 2012;15:500–503. [PubMed] [Google Scholar]
  21. Shakoor S, Kabir F, Khowaja AR, et al. - Pneumococcal Serotypes and Serogroups Causing Invasive Disease in Pakistan, 2005–2013. PLOS ONE. 2014;9:e98796. doi: 10.1371/journal.pone.0098796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bokaeian M, Khazaei H, Javadimehr M. - Nasopharyngeal carriage, antibiotic resistance and serotype distribution of Streptococcus pneumoniae among healthy adolescents in Zahedan. IRCMJ. 2011;13:328. [PMC free article] [PubMed] [Google Scholar]
  23. Bogaert D, van Belkum A, Slu. ter M, et al. - Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. LANCET. 2004;363:1871–1872. doi: 10.1016/S0140-6736(04)16357-5. [DOI] [PubMed] [Google Scholar]
  24. Kyaw MH, Lynfi eld R, Schaff ner W, et al. - Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. NEJM. 2006;354:1455–63. doi: 10.1056/NEJMoa051642. [DOI] [PubMed] [Google Scholar]
  25. Hausdorff WP, Siber G, Paradiso PR. - Geographical diff erences in invasive pneumococcal disease rates and serotype frequency in young children. LANCET. 2001;357:950–952. doi: 10.1016/S0140-6736(00)04222-7. [DOI] [PubMed] [Google Scholar]
  26. Oloba ML, Windau A, Bajaksouzian S, et al. – Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. CID. 2001;33:1489–1494. doi: 10.1086/323027. [DOI] [PubMed] [Google Scholar]

Articles from Mædica are provided here courtesy of Amaltea Medical, Editura Magister

RESOURCES